SM
Salter Malcolm Director
Board M
US US · SEC (Form 4)
€409,568
▼ Sales (16 ops.)
Discover the detailed record of transactions filed by Salter Malcolm, Director. Officer active across 1 companies, notably C4 Therapeutics, Inc.. Cumulatively, 22 disclosures have been recorded. Total volume traded: €410k. The latest transaction was disclosed on 4 January 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations 22 total
€11,959 428 shares @ €27.9414 0.0065% mcap 5.0% of flow
Common Stock
SEC:0001209191-22-003504 · 4 Jan 2022
€11,959 428 shares @ €27.9414 0.0065% mcap 2.5% of flow
Common Stock
SEC:0001209191-22-003504:0 · 4 Jan 2022
€20,150 755 shares @ €26.6893 0.011% mcap 8.4% of flow
Common Stock
SEC:0001209191-21-070273 · 17 Dec 2021
€20,150 755 shares @ €26.6893 0.011% mcap 4.2% of flow
Common Stock
SEC:0001209191-21-070273:0 · 17 Dec 2021
€26,638 755 shares @ €35.282 0.014% mcap 11.1% of flow
Common Stock
SEC:0001209191-21-065820 · 19 Nov 2021
€26,638 755 shares @ €35.282 0.014% mcap 5.6% of flow
Common Stock
SEC:0001209191-21-065820:0 · 19 Nov 2021
€29,271 755 shares @ €38.7697 0.016% mcap 12.2% of flow
Common Stock
SEC:0001209191-21-060568 · 15 Oct 2021
€29,271 755 shares @ €38.7697 0.016% mcap 6.1% of flow
Common Stock
SEC:0001209191-21-060568:0 · 15 Oct 2021
€11,617 300 shares @ €38.7229 0.0063% mcap 4.8% of flow
Common Stock
SEC:0001209191-21-059530 · 4 Oct 2021
€11,617 300 shares @ €38.7229 0.0063% mcap 2.4% of flow
Common Stock
SEC:0001209191-21-059530:0 · 4 Oct 2021
€32,009 755 shares @ €42.3965 0.017% mcap 13.4% of flow
Common Stock
SEC:0001209191-21-057117 · 17 Sept 2021
€32,009 755 shares @ €42.3965 0.017% mcap 6.7% of flow
Common Stock
SEC:0001209191-21-057117:0 · 17 Sept 2021
€26,336 755 shares @ €34.8817 0.014% mcap 11.0% of flow
Common Stock
SEC:0001209191-21-053162 · 20 Aug 2021
€26,336 755 shares @ €34.8817 0.014% mcap 5.5% of flow
Common Stock
SEC:0001209191-21-053162:0 · 20 Aug 2021
€23,887 755 shares @ €31.6378 0.013% mcap 10.0% of flow
Common Stock
SEC:0001209191-21-047169 · 16 Jul 2021
€23,887 755 shares @ €31.6378 0.013% mcap 5.0% of flow
Common Stock
SEC:0001209191-21-047169:0 · 16 Jul 2021
€11,367 339 shares @ €33.5296 0.0061% mcap 4.7% of flow
Common Stock
SEC:0001209191-21-045808 · 2 Jul 2021
€11,367 339 shares @ €33.5296 0.0061% mcap 2.4% of flow
Common Stock
SEC:0001209191-21-045808:0 · 2 Jul 2021
€23,569 755 shares @ €31.2169 0.013% mcap 9.8% of flow
Common Stock
SEC:0001209191-21-042300 · 18 Jun 2021
€23,569 755 shares @ €31.2169 0.013% mcap 4.9% of flow
Common Stock
SEC:0001209191-21-042300:0 · 18 Jun 2021
€22,924 755 shares @ €30.363 0.012% mcap 9.6% of flow
Common Stock
SEC:0001209191-21-035501 · 21 May 2021
€22,924 755 shares @ €30.363 0.012% mcap 4.8% of flow
Common Stock
SEC:0001209191-21-035501:0 · 21 May 2021
About Salter Malcolm Malcolm Salter is an executive at C4 Therapeutics, Inc.